Structure

Physi-Chem Properties

Molecular Weight:  516.35
Volume:  546.782
LogP:  4.597
LogD:  4.351
LogS:  -4.227
# Rotatable Bonds:  5
TPSA:  93.06
# H-Bond Aceptor:  6
# H-Bond Donor:  2
# Rings:  5
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.372
Synthetic Accessibility Score:  5.245
Fsp3:  0.871
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.435
MDCK Permeability:  2.9583450668724254e-05
Pgp-inhibitor:  0.06
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.006
20% Bioavailability (F20%):  0.014
30% Bioavailability (F30%):  0.633

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.037
Plasma Protein Binding (PPB):  80.66123962402344%
Volume Distribution (VD):  0.445
Pgp-substrate:  13.409614562988281%

ADMET: Metabolism

CYP1A2-inhibitor:  0.006
CYP1A2-substrate:  0.454
CYP2C19-inhibitor:  0.012
CYP2C19-substrate:  0.865
CYP2C9-inhibitor:  0.15
CYP2C9-substrate:  0.194
CYP2D6-inhibitor:  0.002
CYP2D6-substrate:  0.157
CYP3A4-inhibitor:  0.349
CYP3A4-substrate:  0.28

ADMET: Excretion

Clearance (CL):  2.772
Half-life (T1/2):  0.493

ADMET: Toxicity

hERG Blockers:  0.046
Human Hepatotoxicity (H-HT):  0.411
Drug-inuced Liver Injury (DILI):  0.04
AMES Toxicity:  0.005
Rat Oral Acute Toxicity:  0.131
Maximum Recommended Daily Dose:  0.303
Skin Sensitization:  0.23
Carcinogencity:  0.02
Eye Corrosion:  0.051
Eye Irritation:  0.163
Respiratory Toxicity:  0.902

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC253586

Natural Product ID:  NPC253586
Common Name*:   Acanthosessiligenin Ii
IUPAC Name:   n.a.
Synonyms:   Acanthosessiligenin II
Standard InCHIKey:  GMWCFIADDGQIDG-KTJYCLMOSA-N
Standard InCHI:  InChI=1S/C31H48O6/c1-17(2)18-9-12-31(26(34)35)14-13-28(5)19(24(18)31)15-20(32)25-29(28,6)11-10-21-27(3,4)37-22(30(21,25)7)16-23(33)36-8/h18-22,24-25,32H,1,9-16H2,2-8H3,(H,34,35)/t18-,19+,20+,21-,22+,24+,25-,28+,29+,30+,31-/m0/s1
SMILES:  C=C(C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](C[C@H]([C@H]4[C@@]3(C)CC[C@H]3C(C)(C)O[C@H](CC(=O)OC)[C@]43C)O)[C@@H]12)C(=O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2063156
PubChem CID:   60154972
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000258] Steroids and steroid derivatives
        • [CHEMONTID:0003364] Steroid acids
          • [CHEMONTID:0003368] 3-carboxy steroids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO30633 Acanthopanax sessiliflorus n.a. n.a. n.a. Fruits n.a. n.a. PMID[22691179]
NPO30633 Acanthopanax sessiliflorus n.a. n.a. n.a. n.a. n.a. n.a. Database[HerDing]
NPO30633 Acanthopanax sessiliflorus n.a. n.a. n.a. n.a. n.a. n.a. Database[TCM_Taiwan]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT393 Cell Line HCT-116 Homo sapiens IC50 < 10000.0 nM PMID[574186]
NPT83 Cell Line MCF7 Homo sapiens IC50 < 10000.0 nM PMID[574186]
NPT134 Cell Line SK-BR-3 Homo sapiens IC50 < 10000.0 nM PMID[574186]
NPT146 Cell Line SK-OV-3 Homo sapiens IC50 < 10000.0 nM PMID[574186]
NPT165 Cell Line HeLa Homo sapiens IC50 < 10000.0 nM PMID[574186]
NPT65 Cell Line HepG2 Homo sapiens IC50 < 10000.0 nM PMID[574186]
NPT373 Cell Line SK-MEL-5 Homo sapiens IC50 < 10000.0 nM PMID[574186]
NPT113 Cell Line RAW264.7 Mus musculus IC50 = 47000.0 nM PMID[574186]
NPT113 Cell Line RAW264.7 Mus musculus Activity = 91.1 % PMID[574186]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC253586 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9783 High Similarity NPC108371
0.9167 High Similarity NPC124544
0.9032 High Similarity NPC47853
0.8958 High Similarity NPC94906
0.8936 High Similarity NPC205173
0.8925 High Similarity NPC287118
0.8925 High Similarity NPC473690
0.8925 High Similarity NPC471902
0.8866 High Similarity NPC46848
0.8866 High Similarity NPC75941
0.8854 High Similarity NPC16911
0.8854 High Similarity NPC78427
0.8854 High Similarity NPC471038
0.8854 High Similarity NPC119036
0.8854 High Similarity NPC472028
0.8854 High Similarity NPC474793
0.8842 High Similarity NPC329910
0.8824 High Similarity NPC272242
0.8817 High Similarity NPC471901
0.8817 High Similarity NPC475416
0.8804 High Similarity NPC213832
0.8804 High Similarity NPC57954
0.8776 High Similarity NPC275990
0.8763 High Similarity NPC41971
0.8763 High Similarity NPC287676
0.8763 High Similarity NPC180733
0.8763 High Similarity NPC37047
0.875 High Similarity NPC469810
0.8737 High Similarity NPC470229
0.8737 High Similarity NPC288906
0.8737 High Similarity NPC279974
0.8737 High Similarity NPC263135
0.8737 High Similarity NPC470232
0.871 High Similarity NPC10274
0.87 High Similarity NPC472655
0.8696 High Similarity NPC146937
0.8696 High Similarity NPC471900
0.8687 High Similarity NPC87927
0.8673 High Similarity NPC39683
0.8673 High Similarity NPC163963
0.8673 High Similarity NPC289148
0.8673 High Similarity NPC52899
0.8673 High Similarity NPC236585
0.8667 High Similarity NPC299963
0.866 High Similarity NPC38296
0.866 High Similarity NPC38471
0.866 High Similarity NPC98837
0.866 High Similarity NPC20479
0.866 High Similarity NPC28864
0.866 High Similarity NPC162459
0.8654 High Similarity NPC102619
0.8646 High Similarity NPC234564
0.8646 High Similarity NPC200054
0.8646 High Similarity NPC29410
0.8641 High Similarity NPC470311
0.8632 High Similarity NPC475118
0.8632 High Similarity NPC470385
0.8632 High Similarity NPC470386
0.8632 High Similarity NPC277399
0.8617 High Similarity NPC219516
0.8602 High Similarity NPC471043
0.8587 High Similarity NPC134197
0.8587 High Similarity NPC264005
0.8587 High Similarity NPC33768
0.8587 High Similarity NPC269360
0.8586 High Similarity NPC76866
0.8586 High Similarity NPC246736
0.8586 High Similarity NPC88203
0.8586 High Similarity NPC214946
0.8586 High Similarity NPC148628
0.8586 High Similarity NPC286519
0.8586 High Similarity NPC304832
0.8571 High Similarity NPC477656
0.8571 High Similarity NPC293866
0.8571 High Similarity NPC477655
0.8571 High Similarity NPC267921
0.8557 High Similarity NPC190080
0.8557 High Similarity NPC111187
0.8556 High Similarity NPC471037
0.8542 High Similarity NPC210214
0.8542 High Similarity NPC98639
0.8529 High Similarity NPC224414
0.8526 High Similarity NPC199543
0.8526 High Similarity NPC291373
0.8515 High Similarity NPC200957
0.8515 High Similarity NPC295366
0.8515 High Similarity NPC138908
0.8515 High Similarity NPC285927
0.8515 High Similarity NPC37600
0.8511 High Similarity NPC169933
0.85 High Similarity NPC139347
0.85 High Similarity NPC277074
0.85 High Similarity NPC469985
0.85 High Similarity NPC209298
0.85 High Similarity NPC122811
0.8495 Intermediate Similarity NPC250687
0.8495 Intermediate Similarity NPC4309
0.8495 Intermediate Similarity NPC211162
0.8495 Intermediate Similarity NPC48824
0.8495 Intermediate Similarity NPC254572
0.8495 Intermediate Similarity NPC229407
0.8495 Intermediate Similarity NPC183374
0.8485 Intermediate Similarity NPC121218
0.8485 Intermediate Similarity NPC253886
0.8478 Intermediate Similarity NPC12774
0.8478 Intermediate Similarity NPC2783
0.8469 Intermediate Similarity NPC89099
0.8462 Intermediate Similarity NPC473336
0.8462 Intermediate Similarity NPC471044
0.8454 Intermediate Similarity NPC470387
0.8454 Intermediate Similarity NPC116683
0.8454 Intermediate Similarity NPC327788
0.8447 Intermediate Similarity NPC471250
0.8444 Intermediate Similarity NPC472504
0.8431 Intermediate Similarity NPC176949
0.8431 Intermediate Similarity NPC59530
0.8431 Intermediate Similarity NPC166993
0.8431 Intermediate Similarity NPC61071
0.8431 Intermediate Similarity NPC201908
0.8431 Intermediate Similarity NPC96333
0.8431 Intermediate Similarity NPC88833
0.8421 Intermediate Similarity NPC470230
0.8421 Intermediate Similarity NPC471747
0.8421 Intermediate Similarity NPC211403
0.8421 Intermediate Similarity NPC160506
0.8421 Intermediate Similarity NPC198242
0.8416 Intermediate Similarity NPC471293
0.8416 Intermediate Similarity NPC101842
0.8416 Intermediate Similarity NPC98603
0.8416 Intermediate Similarity NPC13149
0.8404 Intermediate Similarity NPC77001
0.8404 Intermediate Similarity NPC253618
0.8404 Intermediate Similarity NPC269267
0.84 Intermediate Similarity NPC22388
0.84 Intermediate Similarity NPC473788
0.84 Intermediate Similarity NPC170615
0.84 Intermediate Similarity NPC475558
0.8384 Intermediate Similarity NPC470388
0.837 Intermediate Similarity NPC294438
0.837 Intermediate Similarity NPC264317
0.8367 Intermediate Similarity NPC10864
0.8367 Intermediate Similarity NPC170978
0.8365 Intermediate Similarity NPC106760
0.8365 Intermediate Similarity NPC101450
0.8351 Intermediate Similarity NPC197158
0.8351 Intermediate Similarity NPC471624
0.8351 Intermediate Similarity NPC266431
0.835 Intermediate Similarity NPC469845
0.835 Intermediate Similarity NPC218123
0.835 Intermediate Similarity NPC258323
0.835 Intermediate Similarity NPC112895
0.835 Intermediate Similarity NPC273155
0.835 Intermediate Similarity NPC231278
0.8333 Intermediate Similarity NPC244356
0.8333 Intermediate Similarity NPC224060
0.8333 Intermediate Similarity NPC475061
0.8333 Intermediate Similarity NPC294263
0.8333 Intermediate Similarity NPC470224
0.8317 Intermediate Similarity NPC36688
0.8317 Intermediate Similarity NPC216114
0.8317 Intermediate Similarity NPC222153
0.8317 Intermediate Similarity NPC140723
0.8317 Intermediate Similarity NPC96217
0.8316 Intermediate Similarity NPC194485
0.8316 Intermediate Similarity NPC53890
0.8316 Intermediate Similarity NPC219937
0.8316 Intermediate Similarity NPC123252
0.8316 Intermediate Similarity NPC46758
0.8302 Intermediate Similarity NPC52634
0.83 Intermediate Similarity NPC477052
0.83 Intermediate Similarity NPC148279
0.83 Intermediate Similarity NPC71706
0.83 Intermediate Similarity NPC252614
0.83 Intermediate Similarity NPC477053
0.83 Intermediate Similarity NPC477051
0.8298 Intermediate Similarity NPC16377
0.8298 Intermediate Similarity NPC160304
0.8298 Intermediate Similarity NPC255176
0.8298 Intermediate Similarity NPC474719
0.8286 Intermediate Similarity NPC11035
0.8286 Intermediate Similarity NPC471251
0.8283 Intermediate Similarity NPC164349
0.828 Intermediate Similarity NPC80590
0.8269 Intermediate Similarity NPC218853
0.8265 Intermediate Similarity NPC256227
0.8265 Intermediate Similarity NPC120708
0.8265 Intermediate Similarity NPC13949
0.8261 Intermediate Similarity NPC97505
0.8247 Intermediate Similarity NPC303863
0.8247 Intermediate Similarity NPC469982
0.8235 Intermediate Similarity NPC47281
0.8235 Intermediate Similarity NPC301787
0.8235 Intermediate Similarity NPC84928
0.8229 Intermediate Similarity NPC198054
0.8229 Intermediate Similarity NPC250753
0.8229 Intermediate Similarity NPC130840
0.8222 Intermediate Similarity NPC206735
0.8218 Intermediate Similarity NPC477054
0.8218 Intermediate Similarity NPC193934
0.8218 Intermediate Similarity NPC271980

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC253586 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8421 Intermediate Similarity NPD8035 Phase 2
0.8421 Intermediate Similarity NPD8034 Phase 2
0.837 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD6114 Approved
0.8 Intermediate Similarity NPD6118 Approved
0.8 Intermediate Similarity NPD6697 Approved
0.8 Intermediate Similarity NPD6115 Approved
0.7921 Intermediate Similarity NPD7638 Approved
0.7889 Intermediate Similarity NPD6116 Phase 1
0.7843 Intermediate Similarity NPD7639 Approved
0.7843 Intermediate Similarity NPD7640 Approved
0.783 Intermediate Similarity NPD7320 Approved
0.781 Intermediate Similarity NPD5739 Approved
0.781 Intermediate Similarity NPD6675 Approved
0.781 Intermediate Similarity NPD7128 Approved
0.781 Intermediate Similarity NPD6402 Approved
0.7778 Intermediate Similarity NPD6399 Phase 3
0.7778 Intermediate Similarity NPD6117 Approved
0.7739 Intermediate Similarity NPD7492 Approved
0.7699 Intermediate Similarity NPD6059 Approved
0.7699 Intermediate Similarity NPD6054 Approved
0.7692 Intermediate Similarity NPD7736 Approved
0.7672 Intermediate Similarity NPD6616 Approved
0.7664 Intermediate Similarity NPD6881 Approved
0.7664 Intermediate Similarity NPD6899 Approved
0.7642 Intermediate Similarity NPD6008 Approved
0.7636 Intermediate Similarity NPD8133 Approved
0.7607 Intermediate Similarity NPD8293 Discontinued
0.7607 Intermediate Similarity NPD7078 Approved
0.7593 Intermediate Similarity NPD6372 Approved
0.7593 Intermediate Similarity NPD6373 Approved
0.757 Intermediate Similarity NPD5697 Approved
0.757 Intermediate Similarity NPD5701 Approved
0.7565 Intermediate Similarity NPD6370 Approved
0.7556 Intermediate Similarity NPD6113 Clinical (unspecified phase)
0.7544 Intermediate Similarity NPD6319 Approved
0.7523 Intermediate Similarity NPD7102 Approved
0.7523 Intermediate Similarity NPD7290 Approved
0.7523 Intermediate Similarity NPD6883 Approved
0.75 Intermediate Similarity NPD5345 Clinical (unspecified phase)
0.7479 Intermediate Similarity NPD7319 Approved
0.7478 Intermediate Similarity NPD6015 Approved
0.7478 Intermediate Similarity NPD6016 Approved
0.7476 Intermediate Similarity NPD6084 Phase 2
0.7476 Intermediate Similarity NPD6083 Phase 2
0.7455 Intermediate Similarity NPD8130 Phase 1
0.7455 Intermediate Similarity NPD6869 Approved
0.7455 Intermediate Similarity NPD6617 Approved
0.7455 Intermediate Similarity NPD6650 Approved
0.7455 Intermediate Similarity NPD6649 Approved
0.7455 Intermediate Similarity NPD6847 Approved
0.7447 Intermediate Similarity NPD7525 Registered
0.7431 Intermediate Similarity NPD6013 Approved
0.7431 Intermediate Similarity NPD6012 Approved
0.7431 Intermediate Similarity NPD6014 Approved
0.7414 Intermediate Similarity NPD5988 Approved
0.7396 Intermediate Similarity NPD4788 Approved
0.7387 Intermediate Similarity NPD6882 Approved
0.7387 Intermediate Similarity NPD8297 Approved
0.7373 Intermediate Similarity NPD7507 Approved
0.7358 Intermediate Similarity NPD7632 Discontinued
0.7353 Intermediate Similarity NPD7748 Approved
0.7339 Intermediate Similarity NPD6011 Approved
0.7327 Intermediate Similarity NPD7515 Phase 2
0.7321 Intermediate Similarity NPD4632 Approved
0.732 Intermediate Similarity NPD4786 Approved
0.7308 Intermediate Similarity NPD7902 Approved
0.7308 Intermediate Similarity NPD4755 Approved
0.73 Intermediate Similarity NPD5328 Approved
0.7297 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7282 Intermediate Similarity NPD6356 Clinical (unspecified phase)
0.7281 Intermediate Similarity NPD7115 Discovery
0.7255 Intermediate Similarity NPD4202 Approved
0.7207 Intermediate Similarity NPD4634 Approved
0.7172 Intermediate Similarity NPD3618 Phase 1
0.717 Intermediate Similarity NPD5286 Approved
0.717 Intermediate Similarity NPD4696 Approved
0.717 Intermediate Similarity NPD4700 Approved
0.717 Intermediate Similarity NPD5285 Approved
0.7157 Intermediate Similarity NPD6079 Approved
0.7157 Intermediate Similarity NPD7637 Suspended
0.7143 Intermediate Similarity NPD4808 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD4809 Clinical (unspecified phase)
0.713 Intermediate Similarity NPD6009 Approved
0.7117 Intermediate Similarity NPD4061 Clinical (unspecified phase)
0.7115 Intermediate Similarity NPD5695 Phase 3
0.7113 Intermediate Similarity NPD3667 Approved
0.7107 Intermediate Similarity NPD6033 Approved
0.7097 Intermediate Similarity NPD3703 Phase 2
0.7091 Intermediate Similarity NPD6412 Phase 2
0.7075 Intermediate Similarity NPD5696 Approved
0.7069 Intermediate Similarity NPD7328 Approved
0.7069 Intermediate Similarity NPD7327 Approved
0.7059 Intermediate Similarity NPD7604 Phase 2
0.7043 Intermediate Similarity NPD6274 Approved
0.7037 Intermediate Similarity NPD5224 Approved
0.7037 Intermediate Similarity NPD5211 Phase 2
0.7037 Intermediate Similarity NPD4633 Approved
0.7037 Intermediate Similarity NPD5225 Approved
0.7037 Intermediate Similarity NPD5226 Approved
0.7034 Intermediate Similarity NPD5983 Phase 2
0.703 Intermediate Similarity NPD5737 Approved
0.703 Intermediate Similarity NPD6903 Approved
0.703 Intermediate Similarity NPD6672 Approved
0.703 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.7019 Intermediate Similarity NPD7900 Approved
0.7019 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7009 Intermediate Similarity NPD7101 Approved
0.7009 Intermediate Similarity NPD7100 Approved
0.7009 Intermediate Similarity NPD7516 Approved
0.7 Intermediate Similarity NPD7521 Approved
0.7 Intermediate Similarity NPD7146 Approved
0.7 Intermediate Similarity NPD6684 Approved
0.7 Intermediate Similarity NPD5330 Approved
0.7 Intermediate Similarity NPD6409 Approved
0.7 Intermediate Similarity NPD7334 Approved
0.699 Remote Similarity NPD6411 Approved
0.6983 Remote Similarity NPD8295 Clinical (unspecified phase)
0.6972 Remote Similarity NPD5174 Approved
0.6972 Remote Similarity NPD5175 Approved
0.6964 Remote Similarity NPD8132 Clinical (unspecified phase)
0.6961 Remote Similarity NPD4753 Phase 2
0.6949 Remote Similarity NPD8294 Approved
0.6949 Remote Similarity NPD8377 Approved
0.6944 Remote Similarity NPD1700 Approved
0.6944 Remote Similarity NPD5223 Approved
0.6942 Remote Similarity NPD6336 Discontinued
0.693 Remote Similarity NPD6053 Discontinued
0.6923 Remote Similarity NPD6335 Approved
0.6923 Remote Similarity NPD3699 Clinical (unspecified phase)
0.6923 Remote Similarity NPD3700 Clinical (unspecified phase)
0.6917 Remote Similarity NPD8328 Phase 3
0.6916 Remote Similarity NPD4225 Approved
0.6915 Remote Similarity NPD3702 Approved
0.6909 Remote Similarity NPD5141 Approved
0.6909 Remote Similarity NPD8170 Clinical (unspecified phase)
0.6907 Remote Similarity NPD6928 Phase 2
0.6903 Remote Similarity NPD5955 Clinical (unspecified phase)
0.6891 Remote Similarity NPD8379 Approved
0.6891 Remote Similarity NPD8033 Approved
0.6891 Remote Similarity NPD8335 Approved
0.6891 Remote Similarity NPD6291 Clinical (unspecified phase)
0.6891 Remote Similarity NPD8296 Approved
0.6891 Remote Similarity NPD8380 Approved
0.6891 Remote Similarity NPD6908 Approved
0.6891 Remote Similarity NPD6909 Approved
0.6891 Remote Similarity NPD8378 Approved
0.6887 Remote Similarity NPD5222 Approved
0.6887 Remote Similarity NPD4697 Phase 3
0.6887 Remote Similarity NPD5221 Approved
0.6887 Remote Similarity NPD5220 Clinical (unspecified phase)
0.6875 Remote Similarity NPD6686 Approved
0.6857 Remote Similarity NPD6001 Approved
0.6847 Remote Similarity NPD4768 Approved
0.6847 Remote Similarity NPD4767 Approved
0.6838 Remote Similarity NPD6317 Approved
0.6832 Remote Similarity NPD3574 Clinical (unspecified phase)
0.6832 Remote Similarity NPD6098 Approved
0.6822 Remote Similarity NPD5173 Approved
0.6818 Remote Similarity NPD4754 Approved
0.6813 Remote Similarity NPD5361 Clinical (unspecified phase)
0.6813 Remote Similarity NPD5360 Phase 3
0.68 Remote Similarity NPD7338 Clinical (unspecified phase)
0.68 Remote Similarity NPD3666 Approved
0.68 Remote Similarity NPD3665 Phase 1
0.68 Remote Similarity NPD3133 Approved
0.6796 Remote Similarity NPD6080 Approved
0.6796 Remote Similarity NPD6673 Approved
0.6796 Remote Similarity NPD5764 Clinical (unspecified phase)
0.6796 Remote Similarity NPD6904 Approved
0.6796 Remote Similarity NPD6101 Approved
0.678 Remote Similarity NPD6313 Approved
0.678 Remote Similarity NPD6314 Approved
0.6777 Remote Similarity NPD6067 Discontinued
0.6774 Remote Similarity NPD5777 Approved
0.6774 Remote Similarity NPD6081 Approved
0.6762 Remote Similarity NPD5779 Approved
0.6762 Remote Similarity NPD5778 Approved
0.6752 Remote Similarity NPD6868 Approved
0.675 Remote Similarity NPD6921 Approved
0.6739 Remote Similarity NPD4267 Clinical (unspecified phase)
0.6726 Remote Similarity NPD4730 Approved
0.6726 Remote Similarity NPD4729 Approved
0.6726 Remote Similarity NPD5128 Approved
0.67 Remote Similarity NPD6695 Phase 3
0.6698 Remote Similarity NPD5282 Discontinued
0.6667 Remote Similarity NPD4789 Approved
0.6667 Remote Similarity NPD4244 Approved
0.6667 Remote Similarity NPD5284 Approved
0.6667 Remote Similarity NPD4245 Approved
0.6667 Remote Similarity NPD5281 Approved
0.6637 Remote Similarity NPD5954 Clinical (unspecified phase)
0.6636 Remote Similarity NPD5210 Approved
0.6636 Remote Similarity NPD4629 Approved
0.6634 Remote Similarity NPD3668 Phase 3
0.6633 Remote Similarity NPD7645 Phase 2
0.6609 Remote Similarity NPD5251 Approved
0.6609 Remote Similarity NPD5250 Approved
0.6609 Remote Similarity NPD5249 Phase 3
0.6609 Remote Similarity NPD5247 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data